David Roux
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
David Roux has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Elnur Garayev
2 shared publicationsEvelyne Ollivier
2 shared publicationsHuguette Sallanon
2 shared publicationsRiad Elias
2 shared publicationsBéatrice Baghdikian
1 shared publication- Béatrice Baghdikian
Service of Pharmacognosy, Faculty of Pharmacy, IMBE, Aix Marseille Univ, Avignon Univ, CNRS 7263, IRD 237, IRD 237, 27 Bd Jean Moulin, Marseille, France.
1 shared publication
Latest Publications
- 1 April 2023
- Published by JLE in Annales de biologie clinique
- Vol. 81 (2) , 168-180
Monitoring of heparinization in cardiac surgery with ACT: accreditation of the point-of-care test in the Bordeaux University Hospital Centre
ACT (Activated Clotting Time) is a point of care test (POCT) on whole blood, used to monitor the heparinization of patients in the operating room in cardiac surgery (ExtraCorporeal Circulation ECC) and in interventional cardiology (TAVI, AF ablation). The ACT is concerned both by the ISO 22 870 standard and French regulations regarding POCT. We performed an important work at the Bordeaux CHU on its accreditation, by rationalizing and making the park uniform (11 HemochronTM Signature Elite), standardizing the training and the habilitation of operators in medical units, introducing periodic quality controls, centralizing in the laboratory the management of the devices and reagents and by connecting it to the laboratory's computer system (Middleware, SIL et expert softwares). One year after, we have some positive feedbacks with only a few technical problems and with only few remarks raised during internal audits.
- 1 April 2023
- Published by JLE in Annales de biologie clinique
- Vol. 81 (2) , 168-180
Monitoring of heparinization in cardiac surgery with ACT: accreditation of the point-of-care test in the Bordeaux University Hospital Centre
ACT (Activated Clotting Time) is a point of care test (POCT) on whole blood, used to monitor the heparinization of patients in the operating room in cardiac surgery (ExtraCorporeal Circulation ECC) and in interventional cardiology (TAVI, AF ablation). The ACT is concerned both by the ISO 22 870 standard and French regulations regarding POCT. We performed an important work at the Bordeaux CHU on its accreditation, by rationalizing and making the park uniform (11 HemochronTM Signature Elite), standardizing the training and the habilitation of operators in medical units, introducing periodic quality controls, centralizing in the laboratory the management of the devices and reagents and by connecting it to the laboratory's computer system (Middleware, SIL et expert softwares). One year after, we have some positive feedbacks with only a few technical problems and with only few remarks raised during internal audits.
- 1 July 2017
- Published by Elsevier in Fitoterapia
- Vol. 120, 79-84
New sesquiterpene acid and inositol derivatives from Inula montana L.
- 1 July 2017
- Published by Elsevier in Fitoterapia
- Vol. 120, 79-84
New sesquiterpene acid and inositol derivatives from Inula montana L.